Research progress of immunotherapy in advanced EGFR mutant non-small cell lung cancer acquired resistance after treated with first-generation EGFR-tyrosine kinase inhibitors

SHI Ran; ZHOU Qian; LIU Li; HE Jingdong

doi:10.3969/j.issn.1009-0460.2021.08.015

Home>Articles>Research progress of immunotherapy in advanced EGFR mutant non-small cell lung cancer acquired resistance after treated with first-generation EGFR-tyrosine kinase inhibitors

DOI: 10.3969/j.issn.1009-0460.2021.08.015

Research progress of immunotherapy in advanced EGFR mutant non-small cell lung cancer acquired resistance after treated with first-generation EGFR-tyrosine kinase inhibitors

SHI Ran

ZHOU Qian

LIU Li

HE Jingdong

Machine-generated Keywords：

Publication Date：2021-08-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 762-766 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2021,26(8)